JTT 606

Drug Profile

JTT 606

Alternative Names: JTT-606

Latest Information Update: 29 Nov 2006

Price : $50

At a glance

  • Originator Japan Tobacco
  • Class Osteoporosis therapies
  • Mechanism of Action RANK ligand inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Osteoporosis

Most Recent Events

  • 13 Mar 2003 No development reported - Preclinical for Osteoporosis in Japan (unspecified route)
  • 02 Apr 2001 Preclinical development for Osteoporosis in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top